GTx, Inc. (NASDAQ:GTXI)
CAPS Rating:
A biopharmaceutical company dedicated to the discovery, development & commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis & bone loss, muscle wasting & other serious medical conditions.
RSS Headlines
Fool UK
Recs
It may not be fair, but the FDA wants data that GTX doesn't have. They don't have cash to do more trials. Sad story.